Comparative effectiveness of GLP-1 receptor agonists on glycaemic control, body weight, and lipidprofile for type 2 diabetes: Systematic review and network meta-analysis
Yao H, Zhang A, Li D, et al.
BMJ. Pub. online 29 Jan 2024.
Leggi
Blu
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
Glucagon secretion and its association with glycaemic control and ketogenesis during sodium-glucosecotransporter 2 inhibition by ipragliflozin in people with type 1 diabetes: Results from the multicentre, open-label, prospective study
Nakamura Y, Horie I, Kitamura T, et al.
Diabetes Obes Metab. Pub. online 23 Jan 2024.
Leggi
Postprandial glucose-management strategies in type 1 diabetes: Current approaches and prospects with precision medicine and artificial intelligence
Jafar A, Pasqua MR
Diabetes Obes Metab. Pub. online 23 Jan 2024.
Leggi
Limitations of 14-day CGM sampling for assessment of hypoglycemia and glycemic variability in type 1 diabetes
Akturk HK
DiabetesTechnol Ther. Pub. online 1 Feb 2024.
Leggi
Neural-net artificial pancreas: A randomized crossover trial of a first-in-class automated insulin delivery algorithm
Kovatchev BP, Frasquet AC, Pryor EC, et al.
Diabetes Technol Ther. Pub. online 26 Jan 2024.
Leggi
Sodium-glucose cotransporter 2 inhibitors and nephrolithiasis risk in patients with type 2 diabetes
Paik JM, Tesfaye H, Curhan GC, et al.
JAMA Intern Med. Pub. online 29 Jan 2024.
Leggi
Impact of socioeconomic status on chronic control and complications of type 1 diabetes mellitus in users of glucose flash systems: A follow-up study
Sebastian-Valles F, Martínez-Alfonso J, Arranz Martin JA, et al.
BMC Med. 2024;22(1):37.
Leggi
Continuous Glucose Monitor Metrics are associated with ED visits and hospitalizations for hypoglycemia and hyperglycemia but have low predictive value
Gilliam LK, Parker MM, Moffet HH, et al.
Diabetes Technol Ther. Pub. online 26 Jan 2024.
Leggi
Does emotional distress predict worse glycemic control over time? Results from the glycemia reduction approaches in diabetes: A comparative effectiveness study (GRADE)
Cherrington AL, Bebu I, Krause-Steinrauf H, et al.
Diabetes Care. 2024: dc230642.
Leggi
Adaptive infusion of a glucagon‐like peptide‐1/glucagon receptor co‐agonist G3215, in adults with overweight or obesity: Results from a phase 1 randomized clinical trial
Hope DCD, Ansari S, Choudhury S, et al.
Diabetes Obes Metab. Pub. online 16 Jan 2024.
Leggi